Advanced search
Publication Cover
Journal of Receptor Research Volume 9, 1989 - Issue 3
Journal homepage
14
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Characterization of Muscarinic Receptors: Type M2 (Subtype B) on Neuro-2A Neuroblastoma Cells

Anne Edwards Department of Microbiology and Immunology, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC, 29405, USA
,
Michel Gillard Department of Microbiology and Immunology, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC, 29405, USA
&
Ezio Merler Department of Microbiology and Immunology, Medical University of South Carolina, 171 Ashley Ave., Charleston, SC, 29405, USA
Pages 259-270 | Published online: 26 Sep 2008

References

  • Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A. S. V., Hulme E. C. Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 1980; 283: 90–92
  • Birdsall N. J. M., Burgen A. S. V., Hammer R., Hulme E. C., Stockton J. Pirenzepine ‐ a ligand with original binding properties to muscarinic receptors. Scand. J. Gastroenterol. 1980; 15(suppl. 66)1–4
  • Luthin G. R., Wolfe B. B. Comparison of the binding of [3H] Pirenzepine and [3H]Quinuclidinylbenzylate binding to muscarinic cholinergic receptors in rat brain. J. of Pharmacol. Exp. Ther. 1984; 228(3)648–655
  • Vickroy T. W., Watson M., Yamamura H. I., Roeski W. R. Neurotransmitter receptor: mechanism of action and regulation, S. Kito, T. Segawa, K. Kuriyama, H. I. Yamamura, R. W. Olsen. Plenum Press, NY 1984; vol. 50: 94–114, 5
  • McKinney M., Richelson E. The coupling of the neuronal muscarinic receptor to responses. Ann. Rev. Pharmacol. Toxicol. 1984; 24: 121–146
  • Gil D. W., Wolfe B. B. Pirenzepine distinguishes between muscarinic receptor‐mediated phosphoinositide breakdown and inhibition of adenylate cyclase. J. Pharmacol. Exp. Ther. 1985; 232: 608–616
  • Brown J. H., Brown S. L. Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism. J. Biol. Chem. 1984; 259: 3777–3781
  • Matsuzawa H., Nirenberg M. Receptor‐mediated shifts in cGMP and cAMP levels in neuroblastoma cells. Proc. Natl. Acad. Sci. 1975; 72: 3472–3476
  • Lichtshtein D., Boone G., Blume A. Muscarinic receptor regulation of NG108–15 adenylate cyclase: Requirement for Na+ and GTP. J. Cyclic Nucleotide Res. 1979; 5: 367–375
  • McKinney M., Richelson E. Muscarinic responses and binding in a murine neuroblastoma clone (NIE‐115): cyclic GMP formation is mediated by a low affinity agonist‐receptor conformation cyclic AMP reduction is mediated by a high affinity agonist‐receptor conformation. Mol. Pharmacol. 1986; 30: 207–211
  • Cohen N. M., Schmidt D. M., McGlennen R. C., Klein W. L. Receptor‐mediated increases in phosphatidylinositol turnover in neuron‐like cell lines. J. Neuro‐chem. 1983; 40: 547–554
  • Fisher S. K., Snider M. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas. Mol. Pharmacol. 1987; 32: 81–90
  • Waelbroeck M., Gillard M., Robberecht P., Christophe J. Muscarinic receptor heterogeneity in the rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type. Mol. Pharmacol. 1987; 32: 91–99
  • Scatchard G. The attractions of proteins for small moecules and ions. Ann. N.Y. Acad. Sci. 1949; 51: 660–672
  • Waelbroeck M., Gillard M., Robberecht P., Christophe J. Kinetic studies of [3H]‐N‐methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites. Mol. Pharmacol. 1986; 30: 305–314
  • Cheng Y., Prusoff W. H. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 1973; 22: 3099–3108
  • Gillard M., Waelbrock M., Christophe J. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H] Oxotremorine‐M correspond to heterogeneous M2 receptors with very high affinity for agonists. Mol. Pharmacol. 1987; 32: 100–108
  • Evans T., Smith M., Tanner L. I., Harden T. K. Muscarinic cholinergic receptors of two cell lines that regulate cyclic AMP metabolism by different molecular mechanisms. Mol. Pharmacol. 1984; 26: 395–404
  • Peralta E., Ashkenazi A., Winslow J., Ramachandran J., Capon D. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature 1988; 334: 434–437
  • Ashkenazi A., Winslow J. W., Peralta E. G., Peterson G. L., Schimerlik M. I., Capon D. J., Ramachandran J. An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover. Science 1987; 238: 672–675

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.